Skip to main content
. 2022 May 5;59(5):2101402. doi: 10.1183/13993003.01402-2021

TABLE 1.

Sociodemographic and disease characteristics presented by asthma severity and practice type

All (n=8351) Primary care (n=1440) Specialists (n=6872)
Investigator-classified mild asthma (n=743) Investigator-classified moderate-to-severe asthma (n=695) All (n=1440) Investigator-classified mild asthma (n=1210) Investigator-classified moderate-to-severe asthma (n=5660) All (n=6872)
Age (years)
 Mean±sd 49.4±16.7 45.8±16.8 50.2±16.4 47.9±16.7 44.7±18.0 50.8±16.2 49.7±16.7
 Median (IQR) 51.0 (37.0–62.0) 47.0 (34.0–58.0) 51.0 (38.0–62.0) 49.0 (36.0–60.0) 44.0 (31.0–59.0) 52.0 (39.0–63.0) 51.0 (38.0–62.0)
Sex
 Female 5691 (68.1) 535 (72.0) 452 (65.0) 988 (68.6) 779 (64.4) 3895 (68.8) 4676 (68.0)
BMI (kg·m−2)
 Mean±sd 27.8±6.19 27.7±6.44 28.1±6.55 27.9±6.49 27.2±6.46 27.9±6.05 27.8±6.13
BMI group (kg·m−2)
 <18.5 256 (3.1) 32 (4.3) 15 (2.2) 47 (3.3) 61 (5.0) 148 (2.6) 209 (3.0)
 ≥18.5–24.9 2619 (31.4) 241 (32.4) 232 (33.4) 474 (32.9) 402 (33.2) 1734 (30.6) 2136 (31.1)
 ≥25.0–29.9 2954 (35.4) 247 (33.2) 230 (33.1) 477 (33.1) 430 (35.5) 2031 (35.9) 2463 (35.8)
 ≥30.0 2522 (30.2) 223 (30.0) 218 (31.4) 442 (30.7) 317 (26.2) 1747 (30.9) 2064 (30.0)
Education level
 Primary or secondary school 2877 (34.5) 346 (46.6) 187 (26.9) 533 (37.0) 393 (32.5) 1937 (34.2) 2330 (33.9)
 High school 2013 (24.1) 166 (22.3) 151 (21.7) 318 (22.1) 373 (30.8) 1312 (23.2) 1685 (24.5)
 University and/or post-university 2792 (33.4) 203 (27.3) 297 (42.7) 501 (34.8) 392 (32.4) 1887 (33.3) 2281 (33.2)
 Not established 668 (8.0) 28 (3.8) 60 (8.6) 88 (6.1) 52 (4.3) 523 (9.2) 575 (8.4)
 Missing data 1 0 0 0 0 1 1
Healthcare/medication funding
 Not reimbursed 2281 (27.3) 320 (43.1) 191 (27.5) 511 (35.5) 444 (36.7) 1317 (23.3) 1762 (25.6)
 Partially reimbursed 1851 (22.2) 152 (20.5) 196 (28.2) 348 (24.2) 241 (19.9) 1253 (22.1) 1494 (21.7)
 Fully reimbursed 3940 (47.2) 258 (34.7) 281 (40.4) 539 (37.4) 507 (41.9) 2871 (50.7) 3379 (49.2)
 Not specified 276 (3.3) 13 (1.7) 27 (3.9) 42 (2.9) 18 (1.5) 216 (3.8) 234 (3.4)
 Missing data 3 0 0 0 0 3 3
Smoking status history
 Active smoker 497 (6.0) 27 (3.6) 63 (9.1) 91 (6.3) 81 (6.7) 322 (5.7) 403 (5.9)
 Former smoker 1105 (13.2) 97 (13.1) 119 (17.1) 216 (15.0) 146 (12.1) 741 (13.1) 887 (12.9)
 Never-smoker 6747 (80.8) 619 (83.3) 513 (73.8) 1133 (78.7) 983 (81.2) 4595 (81.2) 5580 (81.2)
 Missing values 2 0 0 0 0 2 2
Asthma duration (years)
 Mean±sd 14.9±14.31 17.9±14.78 16.5±13.91 17.2±14.37 13.9±13.50 14.6±14.43 14.4±14.27
 Median (IQR) 10.0 (4.0–21.0) 13.0 (7.0–25.5) 13.0 (6.0–22.0) 13.0 (6.0–24.0) 9.5 (4.0–20.0) 10.0 (4.0–20.0) 10.0 (4.0–20.0)
GINA treatment step
 Step 1 714 (8.5) 316 (42.5) 0 (0) 316 (21.9) 396 (32.7) 0 (0) 396 (5.8)
 Step 2 1244 (14.9) 427 (57.5) 0 (0) 427 (29.7) 814 (67.3) 0 (0) 814 (11.8)
 Step 3 2279 (27.3) 0 (0) 371 (53.4) 371 (25.8) 0 (0) 1900 (33.6) 1900 (27.6)
 Step 4 2872 (34.4) 0 (0) 261 (37.6) 261 (18.2) 0 (0) 2595 (45.8) 2595 (37.8)
 Step 5 1237 (14.8) 0 (0) 63 (9.1) 63 (4.4) 0 (0) 1165 (20.6) 1165 (17.0)
 Missing data 5 0 0 2 0 0 2
Comorbidities
 None 2962 (35.5) 328 (44.1) 264 (38.0) 593 (41.2) 535 (44.2) 1822 (32.2) 2358 (34.3)
 1–2 3900 (46.7) 319 (42.9) 276 (39.7) 596 (41.4) 512 (42.3) 2773 (49.0) 3286 (47.8)
 3–4 1228 (14.7) 89 (12.0) 126 (18.1) 215 (14.9) 136 (11.2) 870 (15.4) 1006 (14.6)
 ≥5 261 (3.1) 7 (0.9) 29 (4.2) 36 (2.5) 27 (2.2) 195 (3.4) 222 (3.2)

Data are presented as n (%) or n, unless otherwise stated. IQR: interquartile range; BMI: body mass index; GINA: Global Initiative for Asthma.